Sandu Pharmaceuticals Ltd Quarterly Result
Sandu Pharmaceuticals Ltd
NSE: SANDUPHARMA
Net Profit - Last Quarter
Sandu Pharmaceuticals Ltd Quarterly Results Key Highlights
- The revenue of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 14.14 crore as compare to the Dec '24 revenue of ₹ 18.4 crore.
- This represent the decline of -23.15% The ebitda of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 0.52 crore as compare to the Dec '24 ebitda of ₹ 1.02 crore.
- This represent the decline of -49.02% The net profit of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 0.33 crore as compare to the Dec '24 net profit of ₹ 0.56 crore.
- This represent the decline of -41.07%.
Sandu Pharmaceuticals Ltd Quarterly Results Analysis
Market Price of Sandu Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 14 May 2026 | 37.19 |
| 13 May 2026 | 37.48 |
| 12 May 2026 | 38.46 |
| 11 May 2026 | 39.02 |
| 08 May 2026 | 39.32 |
| 07 May 2026 | 40.03 |
| 06 May 2026 | 41.9 |
| 05 May 2026 | 42.11 |
| 04 May 2026 | 42.99 |
| 30 Apr 2026 | 44 |
Historical Revenue of Sandu Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Sandu Pharmaceuticals Ltd
Historical EBITDA of Sandu Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Sandu Pharmaceuticals Ltd
Historical Net Profit of Sandu Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Sandu Pharmaceuticals Ltd
Sandu Pharmaceuticals Ltd News Hub
Sandu Pharmaceuticals AGM scheduled
Sandu Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the company will be he
Read more
13 Aug 24
Board of Sandu Pharmaceuticals recommends final dividend
Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12
Read more
13 Aug 24
Sandu Pharmaceuticals consolidated net profit rises 54.55% in the June 2024 quarter
Net profit of Sandu Pharmaceuticals rose 54.55% to Rs 0.17 crore in the quarter ended June 2024 as a
Read more
13 Aug 24
Sandu Pharmaceuticals schedules board meeting
Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 August 2024
Read more
06 Aug 24
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
About Sandu Pharmaceuticals Ltd
- Sandu Pharmaceuticals Limited (SPL) was established in 1987.
- The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name 'SANDU' and is having a plant unit in Goa. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
- This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
- Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.
FAQs for Quarterly Results of Sandu Pharmaceuticals Ltd
What key financial metrics are included in Sandu Pharmaceuticals Ltd's quarterly results?
When does Sandu Pharmaceuticals Ltd announce its quarterly results?
How does Sandu Pharmaceuticals Ltd's quarterly performance impact its stock price?
What is the impact of Sandu Pharmaceuticals Ltd's quarterly results on dividends?
Are there any special announcements usually made during Sandu Pharmaceuticals Ltd's quarterly results?
